HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Preoperative chemoradiation (XELOX/RT) therapy for anal canal adenocarcinoma with the metastasis to inguinal lymph node].

Abstract
For a woman with poorly-differentiated anal canal adenocarcinoma in acknowledgment of metastasis to right inguinal lymph node, we gave radiotherapy combined with capecitabine as chemotherapy. Then the next two months, we performed XELOX therapy. Subsequently, we performed laparoscopic rectal amputation+D1 dissection+right groin lymph node dissection. The effect of preoperative chemoradiotherapy and pathological examination of the main tumor was Grade 2. And the right inguinal lymph node showed only a mucous persistence. Capecitabine was given as an adjuvant postoperative treatment and did not show a recurrence for five months after the operation. For a treatment for anal canal adenocarcinoma in acknowledgment of metastasis to inguinal lymph node, preoperative chemoradiotherapy may be effective.
AuthorsShunichirou Makino, Yoshihito Ide, Kohei Murata
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 38 Issue 12 Pg. 2048-50 (Nov 2011) ISSN: 0385-0684 [Print] Japan
PMID22202280 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Oxaloacetates
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil
Topics
  • Adenocarcinoma (pathology, therapy)
  • Anal Canal (pathology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Anus Neoplasms (pathology, therapy)
  • Capecitabine
  • Chemoradiotherapy
  • Deoxycytidine (analogs & derivatives, therapeutic use)
  • Female
  • Fluorouracil (analogs & derivatives, therapeutic use)
  • Humans
  • Inguinal Canal (pathology)
  • Lymphatic Metastasis
  • Middle Aged
  • Oxaloacetates
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: